News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024
Catheter Precision, Inc. reports 15% quarter-over-quarter growth with initial sales of LockeT recorded, generating total revenue of $94,840 for Q2 ending June 30, 2024 -
-
COMMUNIQUÉ DE PRESSE
CRCAM Brie Picardie – déclaration hebdomadaire – Rachats réalisés dans les conditions de l'article 5 du Règlement MAR
Caisse Régionale de Crédit Agricole Mutuel Brie Picardie réalise des rachats conformément au Règlement MAR, avec une approche agrégée et détaillée par jour et par transaction -
-
COMMUNIQUÉ DE PRESSE
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals -
-
COMMUNIQUÉ DE PRESSE
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Zomedica Corp.'s PulseVet Shock Wave Device named Official Shock Wave Therapy Supplier of US Equestrian team veterinarians for major international team events. Partnership with USEF to enhance equine athlete care
